MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字H20234008

August 1, 2023

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂

按C₁₃H₂₁NO₃计 3ml:0.31mg

化学药品

August 1, 2023

Company Information

Applicant Company

岳阳县城关镇荣新路(县生态工业园3号)

Manufacturing Company

湖南省岳阳县生态工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath